Psykiatrifonden

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.2% 0.2% 0.2% 0.2% 0.2%  
Bankruptcy risk  4.0% 5.0% 1.6% 1.3% 1.2%  
Credit score (0-100)  51 44 74 80 81  
Credit rating  BBB BBB A A A  
Credit limit (mDKK)  0.0 0.0 0.0 0.3 0.6  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  47 40 47 42 50  
Gross profit  37.6 32.2 36.3 33.0 40.3  
EBITDA  37.6 32.2 1.0 1.5 -0.5  
EBIT  37.6 32.2 1.0 1.5 -0.5  
Pre-tax profit (PTP)  1.3 -0.1 1.4 -0.7 0.4  
Net earnings  1.3 -0.1 1.4 -0.7 0.4  
Pre-tax profit without non-rec. items  37.6 32.2 1.4 -0.7 0.4  

 
See the entire income statement

Balance sheet (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  10.7 10.6 12.0 11.3 11.7  
Interest-bearing liabilities  0.0 0.0 0.1 0.0 0.0  
Balance sheet total (assets)  46.9 47.1 38.6 25.3 24.5  

Net Debt  0.0 -2.3 -3.2 -5.0 -1.7  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  47 40 47 42 50  
Net sales growth  -10.1% -15.5% 17.1% -10.1% 17.8%  
Gross profit  37.6 32.2 36.3 33.0 40.3  
Gross profit growth  -15.4% -14.4% 12.9% -9.1% 22.3%  
Employees  34 32 35 36 41  
Employee growth %  -15.0% -5.9% 9.4% 2.9% 13.9%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  47 47 39 25 24  
Balance sheet change%  -24.7% 0.5% -18.0% -34.5% -3.4%  
Added value  37.6 32.2 1.0 1.5 -0.5  
Added value %  79.2% 80.2% 2.2% 3.6% -1.1%  
Investments  0 0 0 0 -0  

Net sales trend  -1.0 -2.0 1.0 -1.0 1.0  
EBIT trend  2.0 3.0 4.0 5.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  79.2% 80.2% 2.2% 3.6% -1.1%  
EBIT %  79.2% 80.2% 2.2% 3.6% -1.1%  
EBIT to gross profit (%)  100.0% 100.0% 2.8% 4.6% -1.3%  
Net Earnings %  2.8% -0.3% 2.9% -1.6% 0.9%  
Profit before depreciation and extraordinary items %  2.8% -0.3% 2.9% -1.6% 0.9%  
Pre tax profit less extraordinaries %  79.2% 80.2% 2.9% -1.6% 0.9%  
ROA %  68.8% 68.4% 4.4% 5.4% 1.7%  
ROI %  164.8% 147.4% 11.6% 14.1% 3.4%  
ROE %  13.2% -1.0% 12.3% -5.9% 3.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  11.4% 11.2% 30.9% 44.5% 47.8%  
Relative indebtedness %  76.4% 91.2% 56.8% 33.3% 25.7%  
Relative net indebtedness %  76.4% 85.4% 49.8% 21.5% 22.1%  
Net int. bear. debt to EBITDA, %  0.0% -7.3% -309.5% -332.2% 330.8%  
Gearing %  0.0% 0.0% 1.1% 0.0% 0.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 778.4% 3,661.9% 1.3%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.9 1.2 1.3 1.0 1.0  
Current Ratio  0.9 1.2 1.3 1.1 1.1  
Cash and cash equivalent  0.0 2.3 3.3 5.0 1.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 11.8 15.4 11.1  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  47.3% 78.5% 52.9% 32.9% 24.8%  
Net working capital  -1.3 4.8 5.5 1.0 0.7  
Net working capital %  -2.8% 12.0% 11.7% 2.5% 1.4%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  1 1 1 1 1  
Added value / employee  1 1 0 0 -0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1 1 0 0 -0  
EBIT / employee  1 1 0 0 -0  
Net earnings / employee  0 -0 0 -0 0